Polymorphs of the antiviral drug ganciclovir

Ganciclovir (GCV; systematic name: 2‐amino‐9‐{[(1,3‐dihydroxypropan‐2‐yl)oxy]methyl}‐6,9‐dihydro‐1H‐purin‐6‐one), C₉H₁₃N₅O₄, an antiviral drug for treating cytomegalovirus infections, has two known polymorphs (Forms I and II), but only the structure of the metastable Form II has been reported [Kawamura & Hirayama (2009). X‐ray Struct. Anal. Online , 25 , 51–52]. We describe a successful preparation of GCV Form I and its crystal structure. GCV is an achiral molecule in the sense that its individual conformers, which are generally chiral objects, undergo fast interconversion in the liquid state and cannot be isolated. In the crystalline state, GCV exists as two inversion‐related conformers in Form I and as a single chiral conformer in Form II. This situation is similar to that observed for glycine, also an achiral molecule, whose α‐polymorph contains two inversion‐related conformers, while the γ‐polymorph contains a single conformer that is chiral. The hydrogen bonds are exclusively intermolecular in Form I, but both inter‐ and intramolecular in Form II, which accounts for the different molecular conformations in the two polymorphs.     

Polymorphic forms of bisoprolol fumarate

Bisoprolol fumarate is a beta blocker-type drug substance which has been well known for several decades. However, no relevant data can be found in the literature about its crystal polymorphism. The purpose of this paper was to present two anhydrous forms (Form I and Form II) and a hydrate of bisoprolol fumarate substance. Crystalline forms were studied by various solid-state analytical methods: Fourier transform infrared (FT-IR) spectroscopy, X-ray powder diffraction (XRPD), dynamic vapor sorption (DVS) and thermoanalytical methods (thermogravimetry and differential scanning calorimetry). Thermodynamic stability and solubility of the presented polymorphs were also investigated. Both FT-IR and XRPD methods were found to be suitable for the characterization of the different crystal structures. Thermoanalytical measurements showed that (1) Form I and Form II own clearly different melting points and (2) both Form II and hydrate forms can transform into Form I at higher temperature values. Results of the DVS measurements prove that both Form I and Form II became metastable under extremely humid conditions (>?80% RH) and converted into the hydrate. Thermodynamic stability studies showed that Form I and Form II polymorphs are in enantiotropic relationship with an enantiotropic point at about 40–45 °C. Solubility studies indicated that all of the prepared forms are highly soluble, and no difference was found between them. Considering the recommendations of the corresponding International Conference of Harmonization guideline, it can be stated that no specification is required for crystal polymorphism in case of this substance.

     

Triclabendazole: An Intriguing Case of Co‐existence of Conformational and Tautomeric Polymorphism

The crystal polymorphism of the anthelmintic drug, triclabendazole ( TCB ), is described. Two anhydrates (Forms I and II), three solvates, and an amorphous form have been previously mentioned. This study reports the crystal structures of Forms I ( 1 ) and II ( 2 ). These structures illustrate the uncommon phenomenon of tautomeric polymorphism. TCB exists as two tautomers A and B. Form I (Z′=2) is composed of two molecules of tautomer A while Form II (Z′=1) contains a 1:1 mixture of A and B. The polymorphs are also characterized by using other solid‐state techniques (differential scanning calorimetry (DSC), thermal gravimetric analysis (TGA), PXRD, FT‐IR, and NMR spectroscopy). Form I is the higher melting form (m.p.: 177 °C, ΔH_f=≈105±4 J g^?1) and is the more stable form at room temperature. Form II is the lower melting polymorph (m.p.: 166 °C, ΔH_f=≈86±3 J g^?1) and shows high kinetic stability on storage in comparison to the amorphous form but it transforms readily into Form I in a solution‐mediated process. Crystal structure analysis of co‐crystals 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 further confirms the existence of tautomeric polymorphism in TCB . In 3 and 11 , tautomer A is present whereas in 4 , 5 , 6 , 7 , 8 , 9 , 10 the TCB molecule exists wholly as tautomer B. The DFT calculations suggest that the optimized tautomers A and B have nearly the same energies. Single point energy calculations reveal that tautomer A (in Form I) exists in two low‐energy conformations, whereas in Form II both tautomers A and B exist in an unfavorable high‐energy conformation, stabilized by a five‐point dimer synthon. The structural and thermodynamic features of 1 , 2 , 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 , 11 are discussed in detail. Triclabendazole is an intriguing case in which tautomeric and conformational variations co‐exist in the polymorphs.     

X-ray structural studies on two forms of β-cyclodextrin barbital complexes

The crystal structures of two forms of -cyclodextrin barbital complexes (Form I and Form II) were investigated by X-ray analysis. In Form I crystal, two -cyclodextrin(-CyD) molecules including two barbital molecules form a dimeric structure by the hydrogen bonds among their secondary hydroxyl groups. The unit cell volume of Form II is about twice as large as that of Form I and there exist two -CyD dimers in Form II. Although the (Host)/(Guest) ratio is 1/1, only one barbital molecule can be found in Form II at the present stage. The sinilarities and differences between the two crystal structures are mainly discussed here.     

Conformational Polymorphism in Racemic 2,4-Di-<Emphasis Type="Italic">o</Emphasis>-Benzoyl-6-<Emphasis Type="Italic">o</Emphasis>-Tosyl <Emphasis Type="Italic">myo</Emphasis>-Inositol 1,3,5-Orthoacetate

The title compound, C₂₉H₂₆O₁₀S, yields two conformational polymorphs concomitantly from dichloromethane-methanol mixture; the major polymorph grows as plates (Form I, monoclinic, P2₁/n) and the minor polymorph grows as needles (Form II, triclinic, P-1). The two forms differ mainly in orientation of the tosyl group. In Form I, sulfonyl oxygen of the tosyl group makes intermolecular C −H…O interactions, whereas the same group in Form II is involved in an intramolecular short dipolar S=O…C=O (sulfonyl-carbonyl) contact. The molecular organization and the influence of various weak non-covalent interactions that stabilize these conformers in the crystal lattices are discussed.     

Electrogenerated Fe(I) Porphyrins: Efficient Electrocatalysts for Reductive Dechlorination of DDT in N,N′‐Dimethylformamide

Two iron(I) porphyrins were electrogenerated and then utilized as catalysts for the reductive dechlorination of 1,1‐bis(4‐chlorophenyl)‐2,2,2‐trichloroethane (DDT) in N,N′‐dimethylformamide. No reaction is observed between DDT and the Fe(III) or Fe(II) forms of the porphyrin, but the electrogenerated Fe(I) porphyrin efficiently catalyzes the electroreduction of DDT to give (1,1‐bis(4‐chlorophenyl)‐2,2‐dichloroethane) DDD, (1,1‐bis(4‐chlorophenyl)‐2,2‐dichloroethylene) DDE and (1,1‐bis(4‐chlorophenyl)‐2‐dichloroethane) DDMU as determined by GC‐MS analysis. The reductive dechlorination was monitored by electrochemistry, controlled potential electrolysis and spectroelectrochemistry and a mechanism for the reaction involving the reduced porphyrins and DDT is proposed. Comparisons are also made between the catalytic properties of metalloporphyrins containing iron, cobalt and manganese central metal ions under the same solution conditions.     

Enantiotropic phase transition and twinning in 2,2,3,3,4,4‐hexafluoropentane‐1,5‐diol

Four crystal structure determinations of 2,2,3,3,4,4‐hexafluoropentane‐1,5‐diol (HFPD), C₅H₆F₆O₂, were conducted on a single specimen by varying the temperature. Two polymorphs of HFPD were found to be enantiotropically related as phases (I) and (II), both in the space group P1. These structures contain closely related R₄⁴(20) sheets. A structure determination was completed on form (Ia) at 283 K. Form (Ia) was then supercooled below the phase transition temperature at 279 to 173 K to give form (Ib) for a second structure determination. Metastable form (Ib) was transformed by momentary warming and recooling to give form (II) for a third structure determination at 173 K. Form (II) transformed to form (Ic) upon warming to 283 K. Enantiotropic phase transitions between phases (I) and (II) were confirmed with X‐ray powder diffraction and differential scanning calorimetry. Form (Ia) was found as a twin by nonmerohedry by a reflection in (011). This twinning persists in all phases described. Additional twinning was found after the phase (I) to phase (II) transformation. These two additional twin components are related to the first pair by a 180° rotation about the (012) plane. This latter pair of twins persisted as the specimen was warmed back to form (Ic) at 283 K.     

Reassessment of paracetamol orthorhombic Form III and determination of a novel low‐temperature monoclinic Form III‐m from powder diffraction data

Paracetamol [N‐(4‐hydroxyphenyl)acetamide, C₈H₉NO₂] has several polymorphs, just like many other drugs. The most stable polymorphs, denoted Forms I and II, can be obtained easily and their crystal structures are known. Crystals of the orthorhombic, less stable, room‐temperature Form III are difficult to grow; they need a special recipe to crystallize and suffer from severe preferred orientation. A crystal structure model of Form III has been proposed and solved from a combination of structure prediction and powder X‐ray diffraction (PXRD) [Perrin et al. (2009). Chem. Commun. 22 , 3181–3183]. The final R_wp value of 0.138 and the corresponding considerable residual trace were reasons to check its validity. A new structure determination of Form III using new high‐resolution PXRD data led to a final R_wp value of 0.042 and an improvement of the earlier proposed model. In addition, a reversible phase transition was found at 170–220 K between the orthorhombic Form III and a novel monoclinic Form III‐m. The crystal structure of Form III‐m has been determined and refined from PXRD data to a final R_wp value of 0.059.     

A new polymorph of 2,6‐diaminopyridine

2,6‐Diaminopyridine (26‐DAP, C₅H₇N₃) is a common intermediate in the synthesis of aromatic azo chromophores, which are widespread in the dyes and pigments industry. Sublimation of commercial 26‐DAP powder yielded a new polymorph, denoted Form II, which grew as colorless orthorhombic needles. Recrystallization from acetone or toluene also yielded Form II as the major phase. Thermal analysis shows that Form II is a less stable polymorph and it converts upon heating at 335 K to the previously reported Form I.     

Measuring the Elasticity of Poly‐l‐Proline Helices with Terahertz Spectroscopy

The rigidity of poly‐l ‐proline is an important contributor to the stability of many protein secondary structures, where it has been shown to strongly influence bulk flexibility. The experimental Young's moduli of two known poly‐l ‐proline helical forms, right‐handed all‐cis (Form I) and left‐handed all‐trans (Form II), were determined in the crystalline state by using an approach that combines terahertz time‐domain spectroscopy, X‐ray diffraction, and solid‐state density functional theory. Contrary to expectations, the helices were found to be considerably less rigid than many other natural and synthetic polymers, as well as differing greatly from each other, with Young's moduli of 4.9 and 9.6 GPa for Forms I and II, respectively.     

Thermodynamic Analysis of DSC Data for Acetaminophen Polymorphs

This article provides a thermodynamic analysis of DSC data for acetaminophen polymorphic forms I and II by measurement of heat capacity. Form I is found to have lower heat capacity and free energy and hence better stability than Form II down to at least –30°C. The transition temperature below which Form II becomes more stable was determined to be less than –120°C. Form I is more stable than Form II as a consequence of its higher entropy, since its crystallographic packing arrangement is of larger energy. This revised version was published online in August 2006 with corrections to the Cover Date.     

Synthesis and Bioactivity of Novel N,N'-Diacylhydrazine Derivatives Containing Furan (Ⅱ)

Diacylhydrazines have been found as molting hormone analogs since RH‐5849 was reported as the first nonsteroidal ecdysone agonist in 1988. Optimizations on diacylhydrizines with benzoheterocycle containing oxygen were widely explored in recent years. In order to find novel compounds with high bioactivity, a series of mono‐ ( I ) and di‐acylhydrazine ( II ) derivatives containing furan were designed and synthesized. Their structures were confirmed by ¹H NMR, IR, elemental analyses and single crystal X‐ray diffraction analyses ( II ₇). The bioassay results showed that some of the mono‐acylhydrazine ( I ) derivatives exhibited good larvicidal activity against Culex pipiens pallens at 10 mg/L and better than those of di‐acylhydrazines ( II ). Generally, the anti‐tumor activity of di‐acylhydrazines ( II ) was better than that of mono‐acylhydrazines ( I ).     

Thermo-Induced Single-Crystal-to-Single-Crystal Transformations and Photo-Induced [2+2] Cycloaddition Reactions in Polymorphs of Chalcone-Based Molecular Crystals: Multi-Stimuli Responsive Actuators

The polymorphs of 2ClChMe-4 in Form I (ribbon-like crystal) and Form II (block-like crystal) were prepared, and they exhibited curling/flipping and expansion upon heating on account of single-crystal-to-single-crystal transformations. The irreversible phase transformations occurred separately at 53.2 °C and 57.8 °C for the crystals in Form I and Form II, during which the molecular conformation of 2ClChMe-4 changed and the molecules slipped along the (100) plane. Movement at the molecular level resulted in changes of cell parameters, which in turn led to macroscopic motions of the crystals upon heating. Additionally, the ribbon-like crystals of 2ClChMe-4 showed photo-induced bending driven by [2+2] cycloaddition. Accordingly, an actuator showing reversible bending behavior was fabricated triggered by light and heat successively. Like biomimetic self-actuators, such multi-stimuli mechanical responsive molecular crystals might have potential applications in soft robots, artificial muscles and microfluidic systems.     

Two different modes of halogen bonding in two 4‐nitroimidazole derivatives

In the crystal structures of the two imidazole derivatives 5‐chloro‐1,2‐dimethyl‐4‐nitro‐1H‐imidazole, C₅H₆ClN₃O₂, (I), and 2‐chloro‐1‐methyl‐4‐nitro‐1H‐imidazole, C₄H₄ClN₃O₂, (II), C—Cl...O halogen bonds are the principal specific interactions responsible for the crystal packing. Two different halogen‐bond modes are observed: in (I), there is one very short and directional C—Cl...O contact [Cl...O = 2.899 (1) Å], while in (II), the C—Cl group approaches two different O atoms from two different molecules, and the contacts are longer [3.285 (2) and 3.498 (2) Å] and less directional. In (I), relatively short C—H...O hydrogen bonds provide the secondary interactions for building the crystal structure; in (II), the C—H...O contacts are longer but there is a relatively short π–π contact between molecules related by a centre of symmetry. The molecule of (I) is almost planar, the plane of the nitro group making a dihedral angle of 6.97 (7)° with the mean plane of the imidazole ring. The molecule of (II) has crystallographically imposed mirror symmetry and the nitro group lies in the mirror plane.     

Polymorphic Characterization and Bioavailability of Nomegestrol Acetate

Polymorph screening is currently one of the most important strategies of innovators and generic companies from both pharmaceutical and intellectual property rights perspectives. Different polymorphs may have varying physicochemical properties which influence the bioavailability. The purpose of this study was to investigate the crystal structures and physicochemical properties of Nomegestrol acetate(NOMAC) polymorphs. Forms I and II(dioxane solvate) were isolated and prepared by systemic crystallization screening in this study, and the forms are reported for the first time. A structural analysis and comparison of all the forms are presented. This study was also the first time to apply a rapid and feasible ultra-highperformance-liquid chromatography(UHPLC)-electrospray ionization(ESI)-tandem mass spectrometry(MS) method to determine plasma levels of NOMAC within 3.0 mins. And this study demonstrated that the optimal crystal Form I displayed higher bioavailability than API indicating that Form I could be an alternative solid form that needs further research.     

Alkali scandium arsenates. I. The framework structures of KSc(HAsO4)2 and RbScAs2O7

The crystal structures of hydro­thermally synthesized potassium scandium hydrogen arsenate(V), KSc(HAsO₄)₂, (I), and rubidium scandium diarsenate(V), RbScAs₂O₇, (II), were determined from single‐crystal X‐ray diffraction data collected at room temperature. Compound (I) represents a new microporous structure type, designated MCV‐3, which is characterized by a three‐dimensional framework of corner‐sharing alternating ScO₆ octahedra and HAsO₄ tetrahedra. Intersecting tunnels parallel to [101] and [110] host eight‐coordinate K atoms. There is one hydrogen bond of medium strength [O⋯O = 2.7153 (18) Å]. Compound (II) is the first reported diarsenate with a KAlP₂O₇‐type structure and is isotypic with at least 27 A^IM^III diphosphates. The average Sc—O bond lengths in (I) and (II) are 2.09 (2) and 2.09 (3) Å, respectively. The K and Sc atoms in (I) lie on an inversion centre and a twofold axis, respectively. All atoms in (II) are in general positions.     

Multiple melting in nylon 66

Either of the two endothermic melting peaks found by differential thermal analysis of nylon 66 may be converted to the other by appropriate choice of annealing conditions. The two peaks are considered due to the melting of two morphological species, forms I and II. Form I is relatively fixed in melting temperature, while the form II melting temperature varies with annealing conditions and can be either above or below form I. The two forms can be distinguished by whether or not the conversion I → II takes place; if the sample is in form II no change in the thermogram is observed under suitable conversion conditions. The conversion of form I to form II also takes place during cold drawing. It has been previously shown that form I results from rapid cooling from the melt, and form II results from slow cooling. Form I appears to be kinetically favored, while form II is thermodynamically preferred. The variability in the form II melting point is attributed to variable crystal size and/or perfection.     

Reversible Interconversion between Luminescent Isomeric Metal–Organic Frameworks of [Cu4I4(DABCO)2] (DABCO=1,4‐Diazabicyclo[2.2.2]octane)

The metal–organic frameworks (MOF) of cluster [Cu₄I₄(DABCO)₂] (DABCO=1,4‐diazabicyclo[2.2.2]octane) have been prepared and characterized as two different crystalline forms, I and II . Form I is obtained by reaction of DABCO and CuI in aqueous solution or by solvothermal reaction, while form II is obtained by reacting DABCO and CuI in acetonitrile. Their luminescence properties in the solid state have been analyzed at room temperature and at 77 K. MOF II has bright emission with a maximum at 556 nm that shifts bathochromically at low temperature in conjunction with a marked change in the colour of the emission. The emission of MOF I has a maximum at 580 nm and a less pronounced temperature dependence. The peculiar luminescence properties of the two isomers have been interpreted by utilising current knowledge on the excited states properties of Cu^I cubane clusters. The two isomers exhibit a high degree of porosity and can release the disordered solvent molecules trapped in the channels, whilst preserving the crystal structure. Isomer I can be converted into II on exposure to acetonitrile or methanol vapour, whereas II reverts to I when heated in a closed pan at 250 °C.     

Inhibition of paraoxonase 1 by coumarin‐substituted N‐heterocyclic carbene silver(I), ruthenium(II) and palladium(II) complexes

We synthesized three coumarin‐substituted benzimidazolium chlorides and their silver(I), ruthenium(II) and palladium(II) N‐heterocyclic carbene (NHC) complexes. All compounds were characterized using appropriate spectroscopic techniques and elemental analyses. Single‐crystal X‐ray structure of a Pd(II)–NHC complex ( 6b ) was also determined. The inhibitory properties of all compounds were tested on the activity of human paraoxonase 1 (PON1). All complexes exhibited weaker inhibitory properties than their corresponding benzimidazolium salts except for complex 6b which is the most active inhibitor with an IC₅₀ value of 3.01 μM among the compounds reported in this study. A kinetic evaluation showed that this complex inhibits PON1 activity in a non‐competitive manner. Molecular docking studies were also performed for 6b in order to obtain more insight into the binding mode.     

A new conformer of 1,4,7‐tris(p‐tolylsulfonyl)‐1,4,7‐triazacyclononane

A second polymorphic form (form II) of the previously reported 1,4,7‐tris(p‐tolylsulfonyl)‐1,4,7‐triazacyclononane (form I), C₂₇H₃₃N₃O₆S₃, is presented. The molecular structures of the two forms display very different conformations, thus prompting the two forms to crystallize in two different space groups and exhibit quite diverse crystal structure assemblies. Form I crystallizes in the triclinic space group P, while form II crystallizes in the monoclinic space group P2₁/n. The main differences between the two molecular structures are the conformations of the p‐tosyl groups relative to each other and to the macrocyclic ring. The resulting crystal packing displays no classical hydrogen bonds, but different supramolecular synthons give rise to different packing motifs.